Systemic Therapies for Pancreatic Cancer - The Role of Pharmacogenetics

E-ISSN： 1873-5592|13|6|811-828

ISSN： 1389-4501

Source： Current Drug Targets, Vol.13, Iss.6, 2012-05, pp. : 811-828

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pancreatic Cancer: Systemic Combination Therapies for a Heterogeneous Disease

Current Pharmaceutical Design, Vol. 20, Iss. 42, 2014-12 ,pp. : 6660-6669

Bentham Science Publishers

Access to resources Recommend Favorite

Pancreatic cancer: the evolving role of systemic therapy

By El-Rayes Basil F Adsay N Volkan Philip Philip A

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 12, 2001-12 ,pp. : 1939-1947

Informa Healthcare

Access to resources Recommend Favorite

Pancreatic Cancer: A Review of Emerging Therapies

By Rosenberg L.

Drugs, Vol. 59, Iss. 5, 2000-05 ,pp. : 1071-1089

Adis International

Access to resources Recommend Favorite

Role of the RAS in Pancreatic Cancer

Current Cancer Drug Targets, Vol. 11, Iss. 4, 2011-05 ,pp. : 412-420

Bentham Science Publishers

Access to resources Recommend Favorite

Novel treatments and therapies in development for pancreatic cancer

By Löhr Matthias Günzburg Walter H Salmons Brian

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 6, 2002-06 ,pp. : 769-786

Informa Healthcare

Access to resources Recommend Favorite